Fatemeh Tavakoli, Sara Sadat Khatami, Fatemeh Momeni, Javid Azadbakht and Faezeh Ghasemi* Pages 1 - 23 ( 23 )
Gastric cancer (GC) is found as the second leading cause of cancer associated deaths in the world which is usually detected in the advanced stages. It has been showed that surgery is major therapeutic approach in the treatment subjects with GC. Hence, early and fast diagnosis of this malignancy is very important issue for good subject outcomes. Noninvasive diagnostic platforms including evolutionary endoscopy and positron emission tomography (PET) are employed as diagnosis for subjects with GC. Along to imaging techniques, utilization of biomarkers has been emerged as new diagnosis options in early and fast detection of GC. Multiple lines evidence revealed, a variety of biomarkers including microRNAs, exosomes, circulating tumor cells, circular RNAs, cell free DNAs, and various proteins could be used as diagnostic biomarkers in patients with GC. Taken together, these findings suggested that joint application of imaging techniques and different biomarkers, could be introduced as new detection approaches in the treatment and screening response to therapy in the subjects with GC. Herein, we summarized various imaging techniques and biomarkers as powerful tools in the detection of GC.
Gastric cancer, Imaging Techniques, Diagnostic biomarkers, Prognostic biomarkers, Therapeutic biomarkers, Risk factors
Department of Medical Biotechnology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Department of Medical Biotechnology, Faculty of Medicine, Arak University of Medical Sciences, Arak, Isfahan Research Committee of Multiple Sclerosis, Alzahra Research Institute, Alzahra hospital, Isfahan University of Medical Sciences, Isfahan, Department of Radiology and Imaging, Kashan University of Medical Science, Kashan, Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran